Foundation Medicine (FMI) Misses Q2 EPS by 45c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Foundation Medicine (FMI) Misses Q2 EPS by 45c

JMP Securities Downgrades Foundation Medicine (FMI) to Market Perform

July 30, 2015 6:51 AM EDT

JMP Securities downgraded Foundation Medicine (NASDAQ: FMI) from Market Outperform to Market Perform and removed its price target (prior $57.00).

For an analyst ratings summary and ratings history on Foundation Medicine click here. For more ratings news on Foundation Medicine click here.

Shares of Foundation Medicine closed at $29.30 yesterday.

... More

Loxo Oncology (LOXO), University of Colorado Cancer Center Announce Publication of LOXO-101 Phase 1 Data in TRK

July 27, 2015 3:56 PM EDT

The University of Colorado Cancer Center and Loxo Oncology, Inc. (Nasdaq: LOXO), a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development. Additional contributors to the paper include the Knight Cancer Institute at Oregon Health & Science University and Foundation Medicine, Inc. (Nasdaq:... More